Sort   by:  
 Page size 
UnknownB-Raf(V600E) and thrombospondin-1 promote thyroid cancer progression.
Not available
S-EPMC2890809 | biostudies-literature
UnknownVemurafenib-resistance via de novo RBM genes mutations and chromosome 5 aberrations is overcome by combined therapy with palbociclib in thyroid carcinoma with BRAFV600E.
Not available
S-EPMC5689570 | biostudies-literature
UnknownMetastasis-associated MCL1 and P16 copy number alterations dictate resistance to vemurafenib in a BRAFV600E patient-derived papillary thyroid carcinoma preclinical model.
Not available
S-EPMC4767444 | biostudies-literature
UnknownPericytes Elicit Resistance to Vemurafenib and Sorafenib Therapy in Thyroid Carcinoma via the TSP-1/TGFβ1 Axis.
Not available
S-EPMC6279578 | biostudies-literature
Sort   by:  
 Page size